CES2 inhibitors belong to a specific chemical class that is characterized by their ability to selectively block the activity of the enzyme carboxylesterase 2 (CES2). These inhibitors interact with the active site of CES2, preventing its normal enzymatic function. CES2 is a crucial enzyme responsible for the hydrolysis and metabolism of a wide range of endogenous compounds and xenobiotics. By inhibiting CES2, these compounds can potentially modulate the metabolic fate of various substances in the body.
The structural diversity of CES2 inhibitors allows for a versatile approach in developing molecules with varying potency and selectivity against CES2. Researchers are actively investigating these inhibitors' pharmacological properties to understand their implications in interactions and their potential role in modulating metabolism. The precise mechanisms of CES2 inhibitors and their impact on various metabolic pathways are subjects of ongoing research, offering promising avenues for advancements in development and the better understanding of the intricate processes governing xenobiotic metabolism.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol is a form of estrogen hormone, and it has been shown to inhibit CES2 activity. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Telmisartan is an angiotensin II receptor blocker (ARB) used for hypertension, and it has been identified as a CES2 inhibitor. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan is another angiotensin II receptor blocker (ARB) used for hypertension, and it has been shown to inhibit CES2 activity. | ||||||
Ticlopidine Hydrochloride | 53885-35-1 | sc-205861 sc-205861A | 1 g 5 g | $32.00 $99.00 | 2 | |
Ticlopidine is an antiplatelet agent in research used to prevent blood clots, and it has been identified as a CES2 inhibitor. | ||||||